Detection and Analysis of Pyrolysis Products from Waste and Expired Pharmaceuticals

Waste and expired pharmaceuticals are regulated as hazardous waste in most jurisdictions, and when treated by pyrolysis, gasification, or high-temperature incineration they decompose into a complex mixture of fuel gases, condensable oils, and solid residues that may contain persistent organic pollutants, acid gases, and heavy metals. Accurate detection of these pyrolysis products is essential for emission compliance, hazardous waste characterization, and the safe recovery of energy or chemical value from pharmaceutical waste streams. This article explains the sample types, target analytes, analytical methods, quality standards, and applications involved in professional testing of pharmaceutical pyrolysis products.

Technical Overview

Discarded and expired medicines contain pharmacologically active ingredients, organic excipients, polymeric coatings, and residual packaging materials. When these materials are heated in oxygen-free or oxygen-limited conditions—typically between 300 °C and 900 °C—they do not simply burn; instead, they decompose through competing pathways of dehydration, depolymerization, cracking, cyclization, and recombination. The result is a three-phase product stream consisting of non-condensable fuel gas, a condensable pyrolysis oil or tar, and a solid char, each of which can carry hazardous species.

The chemical diversity of pharmaceutical molecules makes the product spectrum unusually broad. Nitrogen-containing drugs can evolve ammonia, hydrogen cyanide, pyridines, quinolines, and anilines; chlorinated compounds and PVC blister packaging can generate hydrogen chloride and chlorinated aromatics; fluorinated active ingredients such as fluoroquinolones can release hydrogen fluoride and fluorinated fragments; and incomplete aromatization produces polycyclic aromatic hydrocarbons (PAHs). Under oxidative or catalytic conditions in real incinerators, chlorinated species may further form polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), which are among the most tightly regulated pollutants in the world.

Systematic detection of pyrolysis products therefore serves three purposes: it characterizes the intrinsic thermal degradation behavior of the waste, it verifies whether process outputs and emissions comply with limits such as those in GB 18484 for hazardous waste incineration, and it supports hazardous waste identification under frameworks such as the GB 5085 series. Accredited third-party laboratories typically combine simulated pyrolysis experiments in the laboratory with sampling and analysis of real process streams to provide a complete picture.

Testing Samples

Testing programs for pharmaceutical pyrolysis products cover both the incoming waste and every output stream of the thermal process. Representative sample categories include the following.

Expired and Obsolete Pharmaceutical Preparations

Source-separated solid dosage forms (tablets, capsules, powders, granules), liquid formulations (syrups, solutions, injectables), semi-solid products (ointments, creams, gels), and associated primary packaging such as PVC-aluminum blister films, bottle resins, and laminated foils. These samples are characterized before treatment to predict product yields and hazard formation potential.

Pyrolysis-Derived Products

Non-condensable syngas collected in gas-tight bags or cylinders, condensable pyrolysis oil and aqueous condensate fractions, and solid char or semi-coke residues. These fractions are analyzed to determine fuel quality, contaminant loading, and suitability for downstream utilization or disposal.

Process Streams and Residues

Flue gas sampled from stacks and ducts, condensate and scrubber liquors, fly ash, bottom ash, and slag from incineration or gasification units treating pharmaceutical waste. Leachates prepared from solid residues are also tested to assess long-term stability before landfilling or resource recovery.

Testing Items

Depending on the objective of the study, the analytical scope typically spans the following groups of target parameters.

• Permanent and fuel gases: hydrogen (H2), carbon monoxide (CO), carbon dioxide (CO2), methane (C1), ethylene and ethane (C2), propane and propylene (C3), and C4 hydrocarbons.
• Volatile organic compounds (VOCs): benzene, toluene, ethylbenzene, and xylenes (BTEX), chloromethanes and chloroethenes, acetone, and other light oxygenates.
• Semi-volatile organic compounds (SVOCs): phenol, cresols, catechols, aniline and substituted anilines, pyridine, quinoline, indoles, amides, nitriles, and nitro-aromatics.
• Polycyclic aromatic hydrocarbons: the priority PAHs from naphthalene through benzo[a]pyrene, including carcinogenic 4-6 ring congeners.
• Halogenated persistent pollutants: PCDD/Fs (dioxins and furans), dioxin-like PCBs, and indicator PCB congeners.
• Acid and corrosive gases: hydrogen chloride (HCl), hydrogen fluoride (HF), hydrogen bromide (HBr), sulfur dioxide (SO2), hydrogen sulfide (H2S), and carbonyl sulfide (COS).
• Nitrogen species: ammonia (NH3), hydrogen cyanide (HCN), nitric oxide and nitrogen dioxide (NOx), and volatile amines.
• Heavy metals and metalloids: mercury, cadmium, lead, arsenic, chromium (including hexavalent chromium), nickel, copper, zinc, manganese, antimony, and tin in chars, ashes, oils, and gas streams.
• Residual active pharmaceutical ingredients and transformation products: antibiotics, hormones, non-steroidal anti-inflammatory drugs, and cytotoxic residues surviving thermal treatment or concentrated in condensates.
• Physicochemical and fuel parameters: gross and net calorific value, moisture, ash, volatile matter, fixed carbon, elemental composition (C, H, N, S, O), and total chlorine, fluorine, and bromine.

Testing Methods

Product characterization relies on a combination of thermal analysis, chromatographic separation, and elemental instrumentation, with method selection governed by the sample phase and the regulatory context.

Thermogravimetric and Evolved-Gas Analysis

Thermogravimetric analysis (TGA) performed according to ISO 11358 or ASTM E1131 maps mass-loss stages and char yield across a programmed temperature ramp. When the TGA furnace is coupled online to Fourier-transform infrared spectroscopy (TGA-FTIR) or mass spectrometry (TG-MS), the evolved gases are identified in real time, revealing which functional groups and small molecules are released at each decomposition step.

Pyrolysis-Gas Chromatography/Mass Spectrometry

Curie-point or flash pyrolysis-GC/MS (Py-GC/MS) subjects milligram-scale samples to rapid heating and separates the resulting fragment library with high sensitivity. It is the reference technique for fingerprinting the organic product slate of complex pharmaceutical matrices and for identifying semi-volatile markers such as phenols, anilines, and PAH precursors without extensive sample preparation.

Gas Product Analysis

Permanent gases and light hydrocarbons are quantified by gas chromatography with thermal conductivity and flame ionization detection (GC-TCD/FID), following the analytical logic of ASTM D1945 and ASTM D7833. Sulfur gases are determined by GC with flame photometric or sulfur chemiluminescence detection, and gas composition data feed directly into calorific value and process energy calculations.

Semi-Volatile Organics and Residue Screening

Solvent-extracted oils, condensates, and sorbent-trapped vapors are analyzed by GC-MS in the manner of EPA Method 8270E and related national procedures such as HJ 834. Residual active ingredients and polar transformation products that are poorly suited to GC are determined by HPLC with diode-array detection or LC-MS/MS, which provides the selectivity required for trace antibiotics and hormones in complex tars.

Dioxins, Furans, and PCBs

Acid Gases and Total Halogens

Hydrogen chloride in stack gas is sampled and determined under EN 1911 or EPA Method 26A followed by ion chromatography, while fluoride is measured by ion-selective electrode or ion chromatography. Total halogen and sulfur loads in raw waste and oils are established by oxidative pyrohydrolytic combustion followed by ion chromatography, in line with ASTM D7359, to predict acid gas formation potential before treatment.

Metals and Inorganic Analysis

Acid digests of char, ash, and oil fractions are analyzed by inductively coupled plasma optical emission spectrometry or mass spectrometry (ICP-OES/ICP-MS), consistent with EPA Methods 6010D and 6020B and national counterparts such as HJ 766. Mercury is determined by cold vapor atomic fluorescence or direct thermal decomposition analyzers, and metal partitioning between fly ash, bottom ash, and the gas phase is assessed using EPA Method 29-type stack sampling.

Fuel Property and Leaching Characterization

Gross calorific value of waste and pyrolysis oil is measured by bomb calorimetry according to ASTM D240 or GB/T 213, ultimate analysis follows ASTM D5373, and proximate analysis follows ASTM D5142. Environmental stability of chars is evaluated through leaching protocols such as EPA Method 1311 or HJ/T 299, referenced against the hazardous waste identification criteria of the GB 5085 series.

Applications

Pyrolysis product detection data underpin decisions across the pharmaceutical waste management lifecycle.

• Hazardous waste characterization and disposal route selection for expired drug take-back and manufacturer recall programs.
• Emission compliance verification for incinerators, pyrolysis units, and gasifiers licensed to treat pharmaceutical waste under GB 18484 and comparable international regimes.
• Process design and optimization, including temperature, residence time, and atmosphere selection to suppress dioxin and PAH formation while maximizing syngas yield.
• Feasibility studies for waste-to-energy and chemical recovery, supported by gas composition, calorific value, and oil quality data.
• Research into thermal degradation pathways of active pharmaceutical ingredients and the environmental fate of their transformation products.
• Environmental impact assessment and permitting support for new treatment facilities and hospital waste management systems.
• Forensic and incident investigation, such as identifying combustion markers after illegal open burning of medicines.

FAQ

Why analyze pyrolysis products instead of only the original waste?

Thermal treatment fundamentally changes the chemical identity of pharmaceutical waste. Hazardous species such as dioxins, PAHs, hydrogen cyanide, and acid gases either do not exist in the raw material or exist in chemically bound forms, so compliance and risk decisions must be based on the products actually released, not on the input composition alone.

Which products raise the greatest regulatory concern?

PCDD/Fs, benzo[a]pyrene and other carcinogenic PAHs, hydrogen chloride and hydrogen fluoride, mercury and other heavy metals, and residual cytotoxic or antibiotic compounds attract the strictest limits worldwide. These parameters should be included in any defensible monitoring program for pharmaceutical thermal treatment.

What sample quantities and preservation conditions are required?

Laboratory pyrolysis studies typically require only a few grams of homogenized sample, whereas process verification calls for representative composite sampling of gases, oils, and residues. Gas samples must be collected in inert, leak-tight containers and analyzed promptly; condensates and oils should be stored cold in amber glass with minimal headspace to prevent volatilization and oxidation.

Can pyrolysis oil from pharmaceutical waste be used as fuel?

Only after comprehensive testing. The oil must be screened for water, solids, ash, calorific value, total halogens, sulfur, nitrogen, and metal content, because chlorinated and nitrogen-rich feeds yield corrosive and NOx-prone fuels. Combustion-IC halogen analysis and GC-MS characterization are the key gate-keeping tests before any co-processing or upgrading decision.

What quality assurance should a testing laboratory provide?

Projects of regulatory significance should be entrusted to ISO/IEC 17025-accredited third-party laboratories, with method validation data, isotope-dilution quantification for dioxins, matrix-spiked recoveries for organics, certified reference materials for metals, and full chain-of-custody documentation from sampling to reporting.

How long does a typical testing program take?

Routine TGA, gas composition, and metals packages are often completed within one to two weeks, while isotope-dilution dioxin analysis and comprehensive Py-GC/MS product mapping of novel waste streams may require three to six weeks because of extended clean-up, multiple fractionation steps, and confirmatory reanalysis.